Feasibility without Guesswork: How Deeper Data (and Genomics) Improve Feasibility and Site Identification with Confidence

About this session

Sponsored by TriNetX. Clinical trial feasibility is often slowed by fragmented data and reliance on assumptions, leading to delays, protocol changes, and underperforming sites. This session explores how deeper, connected real-world data—including genomics, clinical notes, and enriched site intelligence—is enabling a more precise, data-driven approach to feasibility and site identification. Attendees will learn how clinical operations teams can evaluate protocol criteria in real time, identify high-performing sites with eligible patient populations, and uncover insights from both structured and unstructured data sources. By replacing guesswork with evidence, organisations can accelerate timelines, reduce risk, and improve study execution from the start.

Speaker

• SE

  Samantha Eells

  Solutions and Market Lead, Solutions Management · TriNetX

  Speaker